nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—CYP2B6—Ifosfamide—testicular cancer	0.0635	0.108	CbGbCtD
Amitriptyline—CYP3A5—Ifosfamide—testicular cancer	0.05	0.0852	CbGbCtD
Amitriptyline—CYP2C8—Ifosfamide—testicular cancer	0.0481	0.0819	CbGbCtD
Amitriptyline—CYP2C19—Ifosfamide—testicular cancer	0.0403	0.0687	CbGbCtD
Amitriptyline—ADRA1B—vas deferens—testicular cancer	0.0344	0.25	CbGeAlD
Amitriptyline—CYP2C9—Ifosfamide—testicular cancer	0.0335	0.0571	CbGbCtD
Amitriptyline—CYP2B6—Cisplatin—testicular cancer	0.0309	0.0526	CbGbCtD
Amitriptyline—CYP2E1—Etoposide—testicular cancer	0.0308	0.0524	CbGbCtD
Amitriptyline—ABCB1—Dactinomycin—testicular cancer	0.0276	0.0469	CbGbCtD
Amitriptyline—CYP3A5—Etoposide—testicular cancer	0.0239	0.0407	CbGbCtD
Amitriptyline—CYP2C8—Etoposide—testicular cancer	0.023	0.0391	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—testicular cancer	0.0207	0.0352	CbGbCtD
Amitriptyline—HTR7—vas deferens—testicular cancer	0.0201	0.146	CbGeAlD
Amitriptyline—ALB—Methotrexate—testicular cancer	0.0197	0.0335	CbGbCtD
Amitriptyline—CYP3A4—Ifosfamide—testicular cancer	0.0195	0.0332	CbGbCtD
Amitriptyline—CYP1A2—Etoposide—testicular cancer	0.0178	0.0303	CbGbCtD
Amitriptyline—ABCB1—Vinblastine—testicular cancer	0.0173	0.0294	CbGbCtD
Amitriptyline—CYP2C9—Cisplatin—testicular cancer	0.0163	0.0278	CbGbCtD
Amitriptyline—CYP2D6—Vinblastine—testicular cancer	0.0163	0.0277	CbGbCtD
Amitriptyline—ABCB1—Cisplatin—testicular cancer	0.0158	0.027	CbGbCtD
Amitriptyline—ABCB1—Etoposide—testicular cancer	0.0156	0.0265	CbGbCtD
Amitriptyline—ABCB1—Doxorubicin—testicular cancer	0.0106	0.0181	CbGbCtD
Amitriptyline—CYP3A4—Vinblastine—testicular cancer	0.0103	0.0176	CbGbCtD
Amitriptyline—ABCB1—Methotrexate—testicular cancer	0.0103	0.0175	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—testicular cancer	0.01	0.017	CbGbCtD
Amitriptyline—CYP3A4—Etoposide—testicular cancer	0.00932	0.0159	CbGbCtD
Amitriptyline—HTR7—vein—testicular cancer	0.00852	0.0619	CbGeAlD
Amitriptyline—CYP3A4—Doxorubicin—testicular cancer	0.00636	0.0108	CbGbCtD
Amitriptyline—HTR2A—vein—testicular cancer	0.00532	0.0386	CbGeAlD
Amitriptyline—NTRK2—gonad—testicular cancer	0.0048	0.0348	CbGeAlD
Amitriptyline—NTRK1—testis—testicular cancer	0.00452	0.0328	CbGeAlD
Amitriptyline—NTRK2—female gonad—testicular cancer	0.0039	0.0283	CbGeAlD
Amitriptyline—NTRK2—testis—testicular cancer	0.00346	0.0251	CbGeAlD
Amitriptyline—KCNQ2—gonad—testicular cancer	0.00335	0.0243	CbGeAlD
Amitriptyline—KCNQ2—female gonad—testicular cancer	0.00272	0.0198	CbGeAlD
Amitriptyline—KCND2—female gonad—testicular cancer	0.00258	0.0187	CbGeAlD
Amitriptyline—NTRK2—lymph node—testicular cancer	0.00251	0.0182	CbGeAlD
Amitriptyline—KCNQ2—testis—testicular cancer	0.00241	0.0175	CbGeAlD
Amitriptyline—KCND2—testis—testicular cancer	0.00228	0.0166	CbGeAlD
Amitriptyline—KCND3—testis—testicular cancer	0.00199	0.0145	CbGeAlD
Amitriptyline—CHRM4—testis—testicular cancer	0.0019	0.0138	CbGeAlD
Amitriptyline—SIGMAR1—seminal vesicle—testicular cancer	0.00177	0.0129	CbGeAlD
Amitriptyline—KCND3—lymph node—testicular cancer	0.00144	0.0105	CbGeAlD
Amitriptyline—SLC6A2—gonad—testicular cancer	0.00114	0.00825	CbGeAlD
Amitriptyline—HRH2—lymph node—testicular cancer	0.00113	0.00817	CbGeAlD
Amitriptyline—OPRM1—testis—testicular cancer	0.00112	0.00812	CbGeAlD
Amitriptyline—ADRA2A—seminal vesicle—testicular cancer	0.00111	0.00807	CbGeAlD
Amitriptyline—HTR7—gonad—testicular cancer	0.0011	0.00795	CbGeAlD
Amitriptyline—CYP2E1—seminal vesicle—testicular cancer	0.00109	0.00789	CbGeAlD
Amitriptyline—SIGMAR1—female gonad—testicular cancer	0.00104	0.00756	CbGeAlD
Amitriptyline—HTR2A—embryo—testicular cancer	0.00101	0.00731	CbGeAlD
Amitriptyline—ALB—testis—testicular cancer	0.000957	0.00695	CbGeAlD
Amitriptyline—CHRM3—female gonad—testicular cancer	0.000935	0.00679	CbGeAlD
Amitriptyline—SIGMAR1—testis—testicular cancer	0.000924	0.00671	CbGeAlD
Amitriptyline—CYP2B6—gonad—testicular cancer	0.000837	0.00608	CbGeAlD
Amitriptyline—CHRM3—testis—testicular cancer	0.000829	0.00602	CbGeAlD
Amitriptyline—SLC6A2—testis—testicular cancer	0.000819	0.00595	CbGeAlD
Amitriptyline—ADRA2A—gonad—testicular cancer	0.000803	0.00583	CbGeAlD
Amitriptyline—ORM1—lymph node—testicular cancer	0.000791	0.00575	CbGeAlD
Amitriptyline—HTR7—testis—testicular cancer	0.000789	0.00573	CbGeAlD
Amitriptyline—DRD2—testis—testicular cancer	0.000746	0.00542	CbGeAlD
Amitriptyline—ALB—lymph node—testicular cancer	0.000694	0.00504	CbGeAlD
Amitriptyline—CYP3A5—female gonad—testicular cancer	0.000685	0.00497	CbGeAlD
Amitriptyline—HTR2A—gonad—testicular cancer	0.000683	0.00496	CbGeAlD
Amitriptyline—CYP2C8—testis—testicular cancer	0.000673	0.00488	CbGeAlD
Amitriptyline—SIGMAR1—lymph node—testicular cancer	0.00067	0.00486	CbGeAlD
Amitriptyline—HRH1—female gonad—testicular cancer	0.000664	0.00482	CbGeAlD
Amitriptyline—ABCB1—embryo—testicular cancer	0.000659	0.00479	CbGeAlD
Amitriptyline—ADRA2A—female gonad—testicular cancer	0.000653	0.00474	CbGeAlD
Amitriptyline—ABCB1—seminal vesicle—testicular cancer	0.000619	0.0045	CbGeAlD
Amitriptyline—CYP2B6—testis—testicular cancer	0.000603	0.00438	CbGeAlD
Amitriptyline—SLC6A2—lymph node—testicular cancer	0.000594	0.00431	CbGeAlD
Amitriptyline—HRH1—testis—testicular cancer	0.000589	0.00428	CbGeAlD
Amitriptyline—ADRA2A—testis—testicular cancer	0.000579	0.0042	CbGeAlD
Amitriptyline—CYP2E1—testis—testicular cancer	0.000566	0.00411	CbGeAlD
Amitriptyline—CYP2D6—female gonad—testicular cancer	0.000506	0.00367	CbGeAlD
Amitriptyline—HTR2A—testis—testicular cancer	0.000492	0.00357	CbGeAlD
Amitriptyline—CYP2D6—testis—testicular cancer	0.000448	0.00326	CbGeAlD
Amitriptyline—Fatigue—Dactinomycin—testicular cancer	0.000448	0.00192	CcSEcCtD
Amitriptyline—ABCB1—gonad—testicular cancer	0.000448	0.00325	CbGeAlD
Amitriptyline—Purpura—Epirubicin—testicular cancer	0.000445	0.00191	CcSEcCtD
Amitriptyline—Hypotension—Ifosfamide—testicular cancer	0.000445	0.0019	CcSEcCtD
Amitriptyline—Vascular purpura—Doxorubicin—testicular cancer	0.000443	0.0019	CcSEcCtD
Amitriptyline—Urticaria—Bleomycin—testicular cancer	0.000442	0.00189	CcSEcCtD
Amitriptyline—Hepatic failure—Doxorubicin—testicular cancer	0.000441	0.00189	CcSEcCtD
Amitriptyline—Body temperature increased—Bleomycin—testicular cancer	0.00044	0.00189	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Epirubicin—testicular cancer	0.000437	0.00187	CcSEcCtD
Amitriptyline—Irritability—Methotrexate—testicular cancer	0.000437	0.00187	CcSEcCtD
Amitriptyline—Dizziness—Vinblastine—testicular cancer	0.000436	0.00187	CcSEcCtD
Amitriptyline—Convulsion—Cisplatin—testicular cancer	0.000436	0.00187	CcSEcCtD
Amitriptyline—Ataxia—Methotrexate—testicular cancer	0.000431	0.00185	CcSEcCtD
Amitriptyline—Osteoarthritis—Epirubicin—testicular cancer	0.000429	0.00184	CcSEcCtD
Amitriptyline—Feeling abnormal—Dactinomycin—testicular cancer	0.000428	0.00183	CcSEcCtD
Amitriptyline—Nausea—Chlorambucil—testicular cancer	0.000427	0.00183	CcSEcCtD
Amitriptyline—Paraesthesia—Ifosfamide—testicular cancer	0.000427	0.00183	CcSEcCtD
Amitriptyline—Ill-defined disorder—Etoposide—testicular cancer	0.000427	0.00183	CcSEcCtD
Amitriptyline—HRH1—lymph node—testicular cancer	0.000427	0.0031	CbGeAlD
Amitriptyline—Anxiety—Cisplatin—testicular cancer	0.000427	0.00183	CcSEcCtD
Amitriptyline—Somnolence—Ifosfamide—testicular cancer	0.000423	0.00181	CcSEcCtD
Amitriptyline—Discomfort—Cisplatin—testicular cancer	0.000423	0.00181	CcSEcCtD
Amitriptyline—ADRA2A—lymph node—testicular cancer	0.00042	0.00305	CbGeAlD
Amitriptyline—Vomiting—Vinblastine—testicular cancer	0.000419	0.0018	CcSEcCtD
Amitriptyline—Malaise—Etoposide—testicular cancer	0.000415	0.00178	CcSEcCtD
Amitriptyline—Decreased appetite—Ifosfamide—testicular cancer	0.000414	0.00177	CcSEcCtD
Amitriptyline—Headache—Vinblastine—testicular cancer	0.000413	0.00177	CcSEcCtD
Amitriptyline—Leukopenia—Etoposide—testicular cancer	0.000412	0.00177	CcSEcCtD
Amitriptyline—Purpura—Doxorubicin—testicular cancer	0.000412	0.00176	CcSEcCtD
Amitriptyline—Body temperature increased—Dactinomycin—testicular cancer	0.000411	0.00176	CcSEcCtD
Amitriptyline—Fatigue—Ifosfamide—testicular cancer	0.00041	0.00176	CcSEcCtD
Amitriptyline—Oedema—Cisplatin—testicular cancer	0.00041	0.00176	CcSEcCtD
Amitriptyline—Constipation—Ifosfamide—testicular cancer	0.000407	0.00174	CcSEcCtD
Amitriptyline—Loss of consciousness—Etoposide—testicular cancer	0.000405	0.00173	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Doxorubicin—testicular cancer	0.000405	0.00173	CcSEcCtD
Amitriptyline—Ataxia—Epirubicin—testicular cancer	0.000403	0.00173	CcSEcCtD
Amitriptyline—Thrombocytopenia—Cisplatin—testicular cancer	0.000402	0.00172	CcSEcCtD
Amitriptyline—Tachycardia—Cisplatin—testicular cancer	0.0004	0.00172	CcSEcCtD
Amitriptyline—Asthenia—Bleomycin—testicular cancer	0.0004	0.00171	CcSEcCtD
Amitriptyline—Convulsion—Etoposide—testicular cancer	0.000399	0.00171	CcSEcCtD
Amitriptyline—Hypertension—Etoposide—testicular cancer	0.000398	0.0017	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—testicular cancer	0.000397	0.0017	CcSEcCtD
Amitriptyline—Hyperhidrosis—Cisplatin—testicular cancer	0.000397	0.0017	CcSEcCtD
Amitriptyline—Pruritus—Bleomycin—testicular cancer	0.000394	0.00169	CcSEcCtD
Amitriptyline—Feeling abnormal—Ifosfamide—testicular cancer	0.000392	0.00168	CcSEcCtD
Amitriptyline—Eosinophilia—Methotrexate—testicular cancer	0.000392	0.00168	CcSEcCtD
Amitriptyline—Nausea—Vinblastine—testicular cancer	0.000392	0.00168	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Epirubicin—testicular cancer	0.000392	0.00168	CcSEcCtD
Amitriptyline—Anorexia—Cisplatin—testicular cancer	0.000391	0.00168	CcSEcCtD
Amitriptyline—Discomfort—Etoposide—testicular cancer	0.000387	0.00166	CcSEcCtD
Amitriptyline—Hypotension—Cisplatin—testicular cancer	0.000383	0.00164	CcSEcCtD
Amitriptyline—Confusional state—Etoposide—testicular cancer	0.000379	0.00162	CcSEcCtD
Amitriptyline—Urticaria—Ifosfamide—testicular cancer	0.000378	0.00162	CcSEcCtD
Amitriptyline—Body temperature increased—Ifosfamide—testicular cancer	0.000376	0.00161	CcSEcCtD
Amitriptyline—Pancytopenia—Methotrexate—testicular cancer	0.000376	0.00161	CcSEcCtD
Amitriptyline—Ataxia—Doxorubicin—testicular cancer	0.000373	0.0016	CcSEcCtD
Amitriptyline—Asthenia—Dactinomycin—testicular cancer	0.000373	0.0016	CcSEcCtD
Amitriptyline—Paraesthesia—Cisplatin—testicular cancer	0.000368	0.00158	CcSEcCtD
Amitriptyline—Thrombocytopenia—Etoposide—testicular cancer	0.000368	0.00158	CcSEcCtD
Amitriptyline—Tachycardia—Etoposide—testicular cancer	0.000367	0.00157	CcSEcCtD
Amitriptyline—Eosinophilia—Epirubicin—testicular cancer	0.000367	0.00157	CcSEcCtD
Amitriptyline—Erectile dysfunction—Methotrexate—testicular cancer	0.000365	0.00156	CcSEcCtD
Amitriptyline—ABCB1—female gonad—testicular cancer	0.000364	0.00264	CbGeAlD
Amitriptyline—Hyperhidrosis—Etoposide—testicular cancer	0.000363	0.00156	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000362	0.00155	CcSEcCtD
Amitriptyline—Anorexia—Etoposide—testicular cancer	0.000358	0.00153	CcSEcCtD
Amitriptyline—Decreased appetite—Cisplatin—testicular cancer	0.000357	0.00153	CcSEcCtD
Amitriptyline—Diarrhoea—Dactinomycin—testicular cancer	0.000355	0.00152	CcSEcCtD
Amitriptyline—Vomiting—Bleomycin—testicular cancer	0.000354	0.00152	CcSEcCtD
Amitriptyline—Drowsiness—Methotrexate—testicular cancer	0.000353	0.00151	CcSEcCtD
Amitriptyline—Pancytopenia—Epirubicin—testicular cancer	0.000352	0.00151	CcSEcCtD
Amitriptyline—Hypotension—Etoposide—testicular cancer	0.000351	0.0015	CcSEcCtD
Amitriptyline—Rash—Bleomycin—testicular cancer	0.000351	0.0015	CcSEcCtD
Amitriptyline—Dermatitis—Bleomycin—testicular cancer	0.000351	0.0015	CcSEcCtD
Amitriptyline—Stomatitis—Methotrexate—testicular cancer	0.000344	0.00147	CcSEcCtD
Amitriptyline—Pollakiuria—Epirubicin—testicular cancer	0.000342	0.00147	CcSEcCtD
Amitriptyline—Asthenia—Ifosfamide—testicular cancer	0.000341	0.00146	CcSEcCtD
Amitriptyline—Eosinophilia—Doxorubicin—testicular cancer	0.000339	0.00145	CcSEcCtD
Amitriptyline—Feeling abnormal—Cisplatin—testicular cancer	0.000338	0.00145	CcSEcCtD
Amitriptyline—Paraesthesia—Etoposide—testicular cancer	0.000338	0.00145	CcSEcCtD
Amitriptyline—Weight increased—Epirubicin—testicular cancer	0.000337	0.00144	CcSEcCtD
Amitriptyline—Pruritus—Ifosfamide—testicular cancer	0.000337	0.00144	CcSEcCtD
Amitriptyline—Somnolence—Etoposide—testicular cancer	0.000334	0.00143	CcSEcCtD
Amitriptyline—Nausea—Bleomycin—testicular cancer	0.000331	0.00142	CcSEcCtD
Amitriptyline—Drowsiness—Epirubicin—testicular cancer	0.00033	0.00142	CcSEcCtD
Amitriptyline—Vomiting—Dactinomycin—testicular cancer	0.00033	0.00141	CcSEcCtD
Amitriptyline—Agranulocytosis—Methotrexate—testicular cancer	0.000329	0.00141	CcSEcCtD
Amitriptyline—Rash—Dactinomycin—testicular cancer	0.000327	0.0014	CcSEcCtD
Amitriptyline—Decreased appetite—Etoposide—testicular cancer	0.000327	0.0014	CcSEcCtD
Amitriptyline—Diarrhoea—Ifosfamide—testicular cancer	0.000326	0.00139	CcSEcCtD
Amitriptyline—Pancytopenia—Doxorubicin—testicular cancer	0.000326	0.00139	CcSEcCtD
Amitriptyline—Body temperature increased—Cisplatin—testicular cancer	0.000324	0.00139	CcSEcCtD
Amitriptyline—Fatigue—Etoposide—testicular cancer	0.000324	0.00139	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Epirubicin—testicular cancer	0.000324	0.00139	CcSEcCtD
Amitriptyline—ABCB1—testis—testicular cancer	0.000323	0.00234	CbGeAlD
Amitriptyline—Stomatitis—Epirubicin—testicular cancer	0.000322	0.00138	CcSEcCtD
Amitriptyline—Jaundice—Epirubicin—testicular cancer	0.000322	0.00138	CcSEcCtD
Amitriptyline—Constipation—Etoposide—testicular cancer	0.000321	0.00138	CcSEcCtD
Amitriptyline—Hepatitis—Methotrexate—testicular cancer	0.000317	0.00136	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—testicular cancer	0.000317	0.00136	CcSEcCtD
Amitriptyline—Dizziness—Ifosfamide—testicular cancer	0.000315	0.00135	CcSEcCtD
Amitriptyline—Weight increased—Doxorubicin—testicular cancer	0.000312	0.00134	CcSEcCtD
Amitriptyline—Feeling abnormal—Etoposide—testicular cancer	0.00031	0.00133	CcSEcCtD
Amitriptyline—Nausea—Dactinomycin—testicular cancer	0.000308	0.00132	CcSEcCtD
Amitriptyline—Agranulocytosis—Epirubicin—testicular cancer	0.000308	0.00132	CcSEcCtD
Amitriptyline—Drowsiness—Doxorubicin—testicular cancer	0.000306	0.00131	CcSEcCtD
Amitriptyline—Vomiting—Ifosfamide—testicular cancer	0.000303	0.0013	CcSEcCtD
Amitriptyline—Rash—Ifosfamide—testicular cancer	0.0003	0.00129	CcSEcCtD
Amitriptyline—Dermatitis—Ifosfamide—testicular cancer	0.0003	0.00128	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Doxorubicin—testicular cancer	0.0003	0.00128	CcSEcCtD
Amitriptyline—Urticaria—Etoposide—testicular cancer	0.000299	0.00128	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—testicular cancer	0.000298	0.00128	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—testicular cancer	0.000298	0.00128	CcSEcCtD
Amitriptyline—Body temperature increased—Etoposide—testicular cancer	0.000297	0.00127	CcSEcCtD
Amitriptyline—Hepatitis—Epirubicin—testicular cancer	0.000297	0.00127	CcSEcCtD
Amitriptyline—Tinnitus—Methotrexate—testicular cancer	0.000295	0.00127	CcSEcCtD
Amitriptyline—Hypoaesthesia—Epirubicin—testicular cancer	0.000295	0.00126	CcSEcCtD
Amitriptyline—Asthenia—Cisplatin—testicular cancer	0.000294	0.00126	CcSEcCtD
Amitriptyline—Agranulocytosis—Doxorubicin—testicular cancer	0.000285	0.00122	CcSEcCtD
Amitriptyline—Nausea—Ifosfamide—testicular cancer	0.000283	0.00121	CcSEcCtD
Amitriptyline—Diarrhoea—Cisplatin—testicular cancer	0.000281	0.0012	CcSEcCtD
Amitriptyline—Alopecia—Methotrexate—testicular cancer	0.00028	0.0012	CcSEcCtD
Amitriptyline—Tinnitus—Epirubicin—testicular cancer	0.000277	0.00118	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—testicular cancer	0.000274	0.00118	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—testicular cancer	0.000273	0.00117	CcSEcCtD
Amitriptyline—Dysgeusia—Methotrexate—testicular cancer	0.00027	0.00116	CcSEcCtD
Amitriptyline—Asthenia—Etoposide—testicular cancer	0.00027	0.00116	CcSEcCtD
Amitriptyline—Pruritus—Etoposide—testicular cancer	0.000266	0.00114	CcSEcCtD
Amitriptyline—Arrhythmia—Epirubicin—testicular cancer	0.000265	0.00113	CcSEcCtD
Amitriptyline—Alopecia—Epirubicin—testicular cancer	0.000262	0.00112	CcSEcCtD
Amitriptyline—Vomiting—Cisplatin—testicular cancer	0.000261	0.00112	CcSEcCtD
Amitriptyline—Vision blurred—Methotrexate—testicular cancer	0.00026	0.00111	CcSEcCtD
Amitriptyline—Rash—Cisplatin—testicular cancer	0.000259	0.00111	CcSEcCtD
Amitriptyline—Dermatitis—Cisplatin—testicular cancer	0.000258	0.00111	CcSEcCtD
Amitriptyline—Diarrhoea—Etoposide—testicular cancer	0.000257	0.0011	CcSEcCtD
Amitriptyline—Ill-defined disorder—Methotrexate—testicular cancer	0.000256	0.0011	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—testicular cancer	0.000256	0.0011	CcSEcCtD
Amitriptyline—Dysgeusia—Epirubicin—testicular cancer	0.000253	0.00108	CcSEcCtD
Amitriptyline—Malaise—Methotrexate—testicular cancer	0.000249	0.00107	CcSEcCtD
Amitriptyline—Dizziness—Etoposide—testicular cancer	0.000249	0.00106	CcSEcCtD
Amitriptyline—Leukopenia—Methotrexate—testicular cancer	0.000247	0.00106	CcSEcCtD
Amitriptyline—Arrhythmia—Doxorubicin—testicular cancer	0.000245	0.00105	CcSEcCtD
Amitriptyline—Nausea—Cisplatin—testicular cancer	0.000244	0.00104	CcSEcCtD
Amitriptyline—Vision blurred—Epirubicin—testicular cancer	0.000243	0.00104	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—testicular cancer	0.000242	0.00104	CcSEcCtD
Amitriptyline—Ill-defined disorder—Epirubicin—testicular cancer	0.00024	0.00103	CcSEcCtD
Amitriptyline—Convulsion—Methotrexate—testicular cancer	0.000239	0.00102	CcSEcCtD
Amitriptyline—Vomiting—Etoposide—testicular cancer	0.000239	0.00102	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—testicular cancer	0.000237	0.00102	CcSEcCtD
Amitriptyline—Rash—Etoposide—testicular cancer	0.000237	0.00102	CcSEcCtD
Amitriptyline—Dermatitis—Etoposide—testicular cancer	0.000237	0.00101	CcSEcCtD
Amitriptyline—Headache—Etoposide—testicular cancer	0.000235	0.00101	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—testicular cancer	0.000234	0.001	CcSEcCtD
Amitriptyline—ABCB1—lymph node—testicular cancer	0.000234	0.0017	CbGeAlD
Amitriptyline—Malaise—Epirubicin—testicular cancer	0.000233	0.000997	CcSEcCtD
Amitriptyline—Discomfort—Methotrexate—testicular cancer	0.000232	0.000994	CcSEcCtD
Amitriptyline—Syncope—Epirubicin—testicular cancer	0.000232	0.000992	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—testicular cancer	0.000231	0.00099	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—testicular cancer	0.000228	0.000977	CcSEcCtD
Amitriptyline—Confusional state—Methotrexate—testicular cancer	0.000227	0.000972	CcSEcCtD
Amitriptyline—Loss of consciousness—Epirubicin—testicular cancer	0.000227	0.000972	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—testicular cancer	0.000225	0.000964	CcSEcCtD
Amitriptyline—Convulsion—Epirubicin—testicular cancer	0.000224	0.000958	CcSEcCtD
Amitriptyline—Nausea—Etoposide—testicular cancer	0.000223	0.000956	CcSEcCtD
Amitriptyline—Hypertension—Epirubicin—testicular cancer	0.000223	0.000955	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—testicular cancer	0.000222	0.000949	CcSEcCtD
Amitriptyline—Thrombocytopenia—Methotrexate—testicular cancer	0.00022	0.000944	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—testicular cancer	0.00022	0.00094	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—testicular cancer	0.000219	0.000938	CcSEcCtD
Amitriptyline—Hyperhidrosis—Methotrexate—testicular cancer	0.000218	0.000932	CcSEcCtD
Amitriptyline—Discomfort—Epirubicin—testicular cancer	0.000217	0.00093	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—testicular cancer	0.000215	0.000923	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—testicular cancer	0.000215	0.000921	CcSEcCtD
Amitriptyline—Anorexia—Methotrexate—testicular cancer	0.000215	0.000919	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—testicular cancer	0.000214	0.000918	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—testicular cancer	0.000214	0.000916	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—testicular cancer	0.000212	0.00091	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—testicular cancer	0.000211	0.000904	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—testicular cancer	0.000211	0.000903	CcSEcCtD
Amitriptyline—Hypotension—Methotrexate—testicular cancer	0.00021	0.000901	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—testicular cancer	0.00021	0.000899	CcSEcCtD
Amitriptyline—Shock—Epirubicin—testicular cancer	0.000207	0.000888	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—testicular cancer	0.000207	0.000887	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—testicular cancer	0.000206	0.000884	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—testicular cancer	0.000206	0.000883	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—testicular cancer	0.000206	0.000881	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—testicular cancer	0.000204	0.000873	CcSEcCtD
Amitriptyline—Insomnia—Methotrexate—testicular cancer	0.000204	0.000872	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—testicular cancer	0.000203	0.000868	CcSEcCtD
Amitriptyline—Paraesthesia—Methotrexate—testicular cancer	0.000202	0.000866	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—testicular cancer	0.000201	0.000861	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—testicular cancer	0.000201	0.00086	CcSEcCtD
Amitriptyline—Somnolence—Methotrexate—testicular cancer	0.0002	0.000857	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—testicular cancer	0.000199	0.000852	CcSEcCtD
Amitriptyline—Dyspepsia—Methotrexate—testicular cancer	0.000198	0.000849	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—testicular cancer	0.000197	0.000843	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—testicular cancer	0.000197	0.000842	CcSEcCtD
Amitriptyline—Decreased appetite—Methotrexate—testicular cancer	0.000196	0.000838	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—testicular cancer	0.000195	0.000835	CcSEcCtD
Amitriptyline—Fatigue—Methotrexate—testicular cancer	0.000194	0.000831	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—testicular cancer	0.000192	0.000822	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—testicular cancer	0.000191	0.000818	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—testicular cancer	0.000191	0.000816	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—testicular cancer	0.00019	0.000815	CcSEcCtD
Amitriptyline—Paraesthesia—Epirubicin—testicular cancer	0.000189	0.00081	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—testicular cancer	0.000188	0.000807	CcSEcCtD
Amitriptyline—Somnolence—Epirubicin—testicular cancer	0.000187	0.000802	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—testicular cancer	0.000186	0.000796	CcSEcCtD
Amitriptyline—Feeling abnormal—Methotrexate—testicular cancer	0.000186	0.000795	CcSEcCtD
Amitriptyline—Dyspepsia—Epirubicin—testicular cancer	0.000185	0.000794	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—testicular cancer	0.000183	0.000785	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—testicular cancer	0.000182	0.00078	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—testicular cancer	0.000182	0.000778	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—testicular cancer	0.00018	0.000772	CcSEcCtD
Amitriptyline—Urticaria—Methotrexate—testicular cancer	0.000179	0.000766	CcSEcCtD
Amitriptyline—Body temperature increased—Methotrexate—testicular cancer	0.000178	0.000762	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—testicular cancer	0.000176	0.000755	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—testicular cancer	0.000175	0.00075	CcSEcCtD
Amitriptyline—Feeling abnormal—Epirubicin—testicular cancer	0.000174	0.000744	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—testicular cancer	0.000173	0.000742	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—testicular cancer	0.000172	0.000735	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—testicular cancer	0.000169	0.000726	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—testicular cancer	0.000168	0.00072	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—testicular cancer	0.000167	0.000717	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—testicular cancer	0.000167	0.000714	CcSEcCtD
Amitriptyline—Body temperature increased—Epirubicin—testicular cancer	0.000167	0.000713	CcSEcCtD
Amitriptyline—Asthenia—Methotrexate—testicular cancer	0.000162	0.000692	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—testicular cancer	0.000161	0.000688	CcSEcCtD
Amitriptyline—Pruritus—Methotrexate—testicular cancer	0.000159	0.000682	CcSEcCtD
Amitriptyline—Urticaria—Doxorubicin—testicular cancer	0.000155	0.000663	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—testicular cancer	0.000154	0.00066	CcSEcCtD
Amitriptyline—Diarrhoea—Methotrexate—testicular cancer	0.000154	0.00066	CcSEcCtD
Amitriptyline—Asthenia—Epirubicin—testicular cancer	0.000151	0.000648	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—testicular cancer	0.000149	0.000639	CcSEcCtD
Amitriptyline—Dizziness—Methotrexate—testicular cancer	0.000149	0.000638	CcSEcCtD
Amitriptyline—Diarrhoea—Epirubicin—testicular cancer	0.000144	0.000618	CcSEcCtD
Amitriptyline—Vomiting—Methotrexate—testicular cancer	0.000143	0.000613	CcSEcCtD
Amitriptyline—Rash—Methotrexate—testicular cancer	0.000142	0.000608	CcSEcCtD
Amitriptyline—Dermatitis—Methotrexate—testicular cancer	0.000142	0.000608	CcSEcCtD
Amitriptyline—Headache—Methotrexate—testicular cancer	0.000141	0.000604	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—testicular cancer	0.00014	0.000599	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—testicular cancer	0.000139	0.000597	CcSEcCtD
Amitriptyline—HTR1B—GPCR downstream signaling—INSL3—testicular cancer	0.000138	0.00334	CbGpPWpGaD
Amitriptyline—Pruritus—Doxorubicin—testicular cancer	0.000138	0.000591	CcSEcCtD
Amitriptyline—KCNQ2—Axon guidance—MMP2—testicular cancer	0.000136	0.00327	CbGpPWpGaD
Amitriptyline—KCNQ3—Axon guidance—MMP2—testicular cancer	0.000136	0.00327	CbGpPWpGaD
Amitriptyline—CHRM4—GPCR downstream signaling—INSL3—testicular cancer	0.000134	0.00324	CbGpPWpGaD
Amitriptyline—Vomiting—Epirubicin—testicular cancer	0.000134	0.000574	CcSEcCtD
Amitriptyline—Nausea—Methotrexate—testicular cancer	0.000134	0.000573	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—testicular cancer	0.000133	0.000571	CcSEcCtD
Amitriptyline—Rash—Epirubicin—testicular cancer	0.000133	0.000569	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—testicular cancer	0.000133	0.000569	CcSEcCtD
Amitriptyline—Headache—Epirubicin—testicular cancer	0.000132	0.000565	CcSEcCtD
Amitriptyline—OPRK1—Signaling by GPCR—INSL3—testicular cancer	0.000131	0.00316	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—INSL3—testicular cancer	0.000129	0.00312	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—INSL3—testicular cancer	0.000129	0.00311	CbGpPWpGaD
Amitriptyline—Dizziness—Doxorubicin—testicular cancer	0.000129	0.000552	CcSEcCtD
Amitriptyline—CHRM5—GPCR downstream signaling—INSL3—testicular cancer	0.000128	0.0031	CbGpPWpGaD
Amitriptyline—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	0.000128	0.0031	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—INSL3—testicular cancer	0.000128	0.0031	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—INSL3—testicular cancer	0.000128	0.00309	CbGpPWpGaD
Amitriptyline—CYP2B6—Biological oxidations—HPGDS—testicular cancer	0.000127	0.00308	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—INSL3—testicular cancer	0.000125	0.00303	CbGpPWpGaD
Amitriptyline—Nausea—Epirubicin—testicular cancer	0.000125	0.000536	CcSEcCtD
Amitriptyline—CYP2E1—Biological oxidations—HPGDS—testicular cancer	0.000125	0.00301	CbGpPWpGaD
Amitriptyline—CYP3A5—Biological oxidations—HPGDS—testicular cancer	0.000125	0.00301	CbGpPWpGaD
Amitriptyline—Vomiting—Doxorubicin—testicular cancer	0.000124	0.000531	CcSEcCtD
Amitriptyline—CHRM4—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000124	0.00298	CbGpPWpGaD
Amitriptyline—Rash—Doxorubicin—testicular cancer	0.000123	0.000527	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—testicular cancer	0.000123	0.000526	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—testicular cancer	0.000122	0.000523	CcSEcCtD
Amitriptyline—OPRM1—GPCR downstream signaling—INSL3—testicular cancer	0.000122	0.00294	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—INSL3—testicular cancer	0.000122	0.00294	CbGpPWpGaD
Amitriptyline—DRD3—GPCR downstream signaling—INSL3—testicular cancer	0.000121	0.00292	CbGpPWpGaD
Amitriptyline—ADRA1D—GPCR downstream signaling—INSL3—testicular cancer	0.000121	0.00292	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling by NGF—FGFR3—testicular cancer	0.000119	0.00288	CbGpPWpGaD
Amitriptyline—CHRM5—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000118	0.00286	CbGpPWpGaD
Amitriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	0.000118	0.00284	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—INSL3—testicular cancer	0.000117	0.00282	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—INSL3—testicular cancer	0.000117	0.00282	CbGpPWpGaD
Amitriptyline—Nausea—Doxorubicin—testicular cancer	0.000116	0.000496	CcSEcCtD
Amitriptyline—OPRM1—Signaling by GPCR—INSL3—testicular cancer	0.000111	0.00267	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—INSL3—testicular cancer	0.00011	0.00265	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—INSL3—testicular cancer	0.00011	0.00265	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling by NGF—KIT—testicular cancer	0.000109	0.00264	CbGpPWpGaD
Amitriptyline—ALB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000108	0.00261	CbGpPWpGaD
Amitriptyline—CYP2C8—Biological oxidations—HPGDS—testicular cancer	0.000108	0.00261	CbGpPWpGaD
Amitriptyline—HTR1A—GPCR downstream signaling—INSL3—testicular cancer	0.000105	0.00254	CbGpPWpGaD
Amitriptyline—HTR2C—GPCR downstream signaling—INSL3—testicular cancer	0.000105	0.00253	CbGpPWpGaD
Amitriptyline—NTRK2—Signaling Pathways—H2AFZ—testicular cancer	0.000103	0.00248	CbGpPWpGaD
Amitriptyline—NTRK2—Signaling Pathways—STK11—testicular cancer	0.000102	0.00247	CbGpPWpGaD
Amitriptyline—ADRA1B—GPCR downstream signaling—INSL3—testicular cancer	0.0001	0.00242	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—INSL3—testicular cancer	9.94e-05	0.0024	CbGpPWpGaD
Amitriptyline—KCNQ2—Developmental Biology—MMP2—testicular cancer	9.68e-05	0.00234	CbGpPWpGaD
Amitriptyline—KCNQ3—Developmental Biology—MMP2—testicular cancer	9.68e-05	0.00234	CbGpPWpGaD
Amitriptyline—CYP2C19—Biological oxidations—HPGDS—testicular cancer	9.63e-05	0.00233	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—INSL3—testicular cancer	9.56e-05	0.00231	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—INSL3—testicular cancer	9.51e-05	0.0023	CbGpPWpGaD
Amitriptyline—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.46e-05	0.00228	CbGpPWpGaD
Amitriptyline—NTRK2—Signaling Pathways—KITLG—testicular cancer	9.45e-05	0.00228	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—INSL3—testicular cancer	9.24e-05	0.00223	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—INSL3—testicular cancer	9.1e-05	0.0022	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—INSL3—testicular cancer	9.09e-05	0.0022	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—INSL3—testicular cancer	9.07e-05	0.00219	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—INSL3—testicular cancer	9.04e-05	0.00218	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—INSL3—testicular cancer	9.01e-05	0.00218	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—INSL3—testicular cancer	8.93e-05	0.00216	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—INSL3—testicular cancer	8.9e-05	0.00215	CbGpPWpGaD
Amitriptyline—CYP2D6—Biological oxidations—HPGDS—testicular cancer	8.86e-05	0.00214	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—INSL3—testicular cancer	8.83e-05	0.00213	CbGpPWpGaD
Amitriptyline—CYP2C9—Biological oxidations—HPGDS—testicular cancer	8.78e-05	0.00212	CbGpPWpGaD
Amitriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	8.64e-05	0.00209	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—INSL3—testicular cancer	8.39e-05	0.00203	CbGpPWpGaD
Amitriptyline—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	8.33e-05	0.00201	CbGpPWpGaD
Amitriptyline—CHRM3—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	8.3e-05	0.002	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—INSL3—testicular cancer	8.27e-05	0.002	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—INSL3—testicular cancer	8.26e-05	0.00199	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—INSL3—testicular cancer	8.24e-05	0.00199	CbGpPWpGaD
Amitriptyline—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	8.22e-05	0.00199	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—INSL3—testicular cancer	8.21e-05	0.00198	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—INSL3—testicular cancer	8.19e-05	0.00198	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—INSL3—testicular cancer	8.11e-05	0.00196	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—INSL3—testicular cancer	8.08e-05	0.00195	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—INSL3—testicular cancer	7.74e-05	0.00187	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—INSL3—testicular cancer	7.63e-05	0.00184	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—INSL3—testicular cancer	7.62e-05	0.00184	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—INSL3—testicular cancer	7.57e-05	0.00183	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—INSL3—testicular cancer	7.51e-05	0.00181	CbGpPWpGaD
Amitriptyline—CYP1A2—Biological oxidations—HPGDS—testicular cancer	7.5e-05	0.00181	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—INSL3—testicular cancer	7.41e-05	0.00179	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—INSL3—testicular cancer	7.19e-05	0.00174	CbGpPWpGaD
Amitriptyline—NTRK2—Signaling Pathways—FGFR3—testicular cancer	7.02e-05	0.0017	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—INSL3—testicular cancer	6.89e-05	0.00166	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—INSL3—testicular cancer	6.54e-05	0.00158	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—INSL3—testicular cancer	6.48e-05	0.00156	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—INSL3—testicular cancer	6.48e-05	0.00156	CbGpPWpGaD
Amitriptyline—NTRK2—Signaling Pathways—KIT—testicular cancer	6.45e-05	0.00156	CbGpPWpGaD
Amitriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	6.28e-05	0.00152	CbGpPWpGaD
Amitriptyline—CYP3A4—Biological oxidations—HPGDS—testicular cancer	5.79e-05	0.0014	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—INSL3—testicular cancer	5.65e-05	0.00136	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—INSL3—testicular cancer	5.62e-05	0.00136	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—INSL3—testicular cancer	5.38e-05	0.0013	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—INSL3—testicular cancer	4.96e-05	0.0012	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—INSL3—testicular cancer	4.88e-05	0.00118	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—INSL3—testicular cancer	4.87e-05	0.00118	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—INSL3—testicular cancer	4.85e-05	0.00117	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—INSL3—testicular cancer	4.84e-05	0.00117	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—INSL3—testicular cancer	4.79e-05	0.00116	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—INSL3—testicular cancer	4.78e-05	0.00115	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—INSL3—testicular cancer	4.44e-05	0.00107	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.14e-05	0.001	CbGpPWpGaD
Amitriptyline—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.12e-05	0.000995	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—H2AFZ—testicular cancer	4.11e-05	0.000991	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—STK11—testicular cancer	4.08e-05	0.000986	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—KITLG—testicular cancer	3.78e-05	0.000912	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—H2AFZ—testicular cancer	3.74e-05	0.000903	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—STK11—testicular cancer	3.72e-05	0.000898	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.7e-05	0.000893	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—KITLG—testicular cancer	3.44e-05	0.000831	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.37e-05	0.000814	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—H2AFZ—testicular cancer	3.18e-05	0.000769	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—STK11—testicular cancer	3.16e-05	0.000764	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—KITLG—testicular cancer	2.93e-05	0.000707	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.88e-05	0.000696	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—H2AFZ—testicular cancer	2.83e-05	0.000682	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—STK11—testicular cancer	2.81e-05	0.000678	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—FGFR3—testicular cancer	2.81e-05	0.000678	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—KITLG—testicular cancer	2.6e-05	0.000628	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—KIT—testicular cancer	2.58e-05	0.000622	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—FGFR3—testicular cancer	2.56e-05	0.000618	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—HPGDS—testicular cancer	2.53e-05	0.000612	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—H2AFZ—testicular cancer	2.48e-05	0.000598	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—STK11—testicular cancer	2.46e-05	0.000595	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—H2AFZ—testicular cancer	2.44e-05	0.00059	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—H2AFZ—testicular cancer	2.44e-05	0.000589	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—STK11—testicular cancer	2.43e-05	0.000586	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—STK11—testicular cancer	2.42e-05	0.000586	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—H2AFZ—testicular cancer	2.42e-05	0.000585	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—STK11—testicular cancer	2.41e-05	0.000582	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—H2AFZ—testicular cancer	2.37e-05	0.000573	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—STK11—testicular cancer	2.36e-05	0.00057	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—KIT—testicular cancer	2.35e-05	0.000567	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—HPGDS—testicular cancer	2.32e-05	0.000561	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—H2AFZ—testicular cancer	2.3e-05	0.000556	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—STK11—testicular cancer	2.29e-05	0.000553	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—KITLG—testicular cancer	2.28e-05	0.00055	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—KITLG—testicular cancer	2.25e-05	0.000542	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—KITLG—testicular cancer	2.24e-05	0.000542	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—KITLG—testicular cancer	2.23e-05	0.000538	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—H2AFZ—testicular cancer	2.21e-05	0.000533	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—STK11—testicular cancer	2.19e-05	0.00053	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—KITLG—testicular cancer	2.18e-05	0.000527	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—HPGDS—testicular cancer	2.18e-05	0.000526	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—FGFR3—testicular cancer	2.18e-05	0.000526	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—HPGDS—testicular cancer	2.13e-05	0.000515	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—HPGDS—testicular cancer	2.13e-05	0.000514	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—KITLG—testicular cancer	2.12e-05	0.000512	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—H2AFZ—testicular cancer	2.09e-05	0.000506	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—STK11—testicular cancer	2.08e-05	0.000503	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—H2AFZ—testicular cancer	2.07e-05	0.000501	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—H2AFZ—testicular cancer	2.07e-05	0.000501	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—STK11—testicular cancer	2.06e-05	0.000498	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—STK11—testicular cancer	2.06e-05	0.000498	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—KITLG—testicular cancer	2.03e-05	0.00049	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—KIT—testicular cancer	2e-05	0.000483	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—FGFR3—testicular cancer	1.93e-05	0.000466	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KITLG—testicular cancer	1.93e-05	0.000465	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KITLG—testicular cancer	1.91e-05	0.000461	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KITLG—testicular cancer	1.91e-05	0.000461	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—HPGDS—testicular cancer	1.84e-05	0.000446	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—STK11—testicular cancer	1.84e-05	0.000445	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—HPGDS—testicular cancer	1.83e-05	0.000443	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	1.81e-05	0.000436	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—H2AFZ—testicular cancer	1.8e-05	0.000434	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—STK11—testicular cancer	1.8e-05	0.000434	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—STK11—testicular cancer	1.79e-05	0.000432	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—KIT—testicular cancer	1.77e-05	0.000428	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—H2AFZ—testicular cancer	1.72e-05	0.000416	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—STK11—testicular cancer	1.71e-05	0.000413	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—FGFR3—testicular cancer	1.69e-05	0.000409	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—STK11—testicular cancer	1.69e-05	0.000408	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—FGFR3—testicular cancer	1.67e-05	0.000403	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—FGFR3—testicular cancer	1.67e-05	0.000403	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KITLG—testicular cancer	1.66e-05	0.000402	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—FGFR3—testicular cancer	1.66e-05	0.0004	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KITLG—testicular cancer	1.65e-05	0.000399	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—HPGDS—testicular cancer	1.65e-05	0.000398	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—FGFR3—testicular cancer	1.62e-05	0.000392	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—HPGDS—testicular cancer	1.61e-05	0.000388	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—H2AFZ—testicular cancer	1.59e-05	0.000383	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—STK11—testicular cancer	1.58e-05	0.000382	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KITLG—testicular cancer	1.58e-05	0.000382	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STK11—testicular cancer	1.58e-05	0.000381	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—FGFR3—testicular cancer	1.57e-05	0.00038	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	1.56e-05	0.000377	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—H2AFZ—testicular cancer	1.56e-05	0.000376	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—KIT—testicular cancer	1.56e-05	0.000376	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—H2AFZ—testicular cancer	1.55e-05	0.000375	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STK11—testicular cancer	1.55e-05	0.000375	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—STK11—testicular cancer	1.55e-05	0.000375	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STK11—testicular cancer	1.55e-05	0.000374	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—H2AFZ—testicular cancer	1.55e-05	0.000374	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—STK11—testicular cancer	1.55e-05	0.000374	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STK11—testicular cancer	1.54e-05	0.000373	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STK11—testicular cancer	1.54e-05	0.000372	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—H2AFZ—testicular cancer	1.53e-05	0.00037	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—KIT—testicular cancer	1.53e-05	0.00037	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—KIT—testicular cancer	1.53e-05	0.00037	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—H2AFZ—testicular cancer	1.53e-05	0.000369	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STK11—testicular cancer	1.52e-05	0.000368	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—KIT—testicular cancer	1.52e-05	0.000367	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STK11—testicular cancer	1.52e-05	0.000367	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—HPGDS—testicular cancer	1.51e-05	0.000366	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—FGFR3—testicular cancer	1.51e-05	0.000364	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—HPGDS—testicular cancer	1.5e-05	0.000363	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—KIT—testicular cancer	1.49e-05	0.00036	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KITLG—testicular cancer	1.46e-05	0.000353	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—KIT—testicular cancer	1.45e-05	0.000349	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KITLG—testicular cancer	1.44e-05	0.000347	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KITLG—testicular cancer	1.43e-05	0.000346	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—FGFR3—testicular cancer	1.43e-05	0.000346	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KITLG—testicular cancer	1.43e-05	0.000345	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KITLG—testicular cancer	1.42e-05	0.000344	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—H2AFZ—testicular cancer	1.42e-05	0.000343	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—FGFR3—testicular cancer	1.42e-05	0.000342	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—FGFR3—testicular cancer	1.42e-05	0.000342	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STK11—testicular cancer	1.41e-05	0.000341	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KITLG—testicular cancer	1.41e-05	0.000341	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KITLG—testicular cancer	1.41e-05	0.00034	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—KIT—testicular cancer	1.38e-05	0.000334	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—STK11—testicular cancer	1.34e-05	0.000324	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—STK11—testicular cancer	1.33e-05	0.000322	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KIT—testicular cancer	1.31e-05	0.000317	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KITLG—testicular cancer	1.31e-05	0.000316	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KIT—testicular cancer	1.3e-05	0.000314	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KIT—testicular cancer	1.3e-05	0.000314	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—HPGDS—testicular cancer	1.28e-05	0.00031	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—FGFR3—testicular cancer	1.24e-05	0.000298	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—FGFR3—testicular cancer	1.23e-05	0.000297	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—STK11—testicular cancer	1.2e-05	0.000289	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—FGFR3—testicular cancer	1.18e-05	0.000284	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—STK11—testicular cancer	1.17e-05	0.000282	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KIT—testicular cancer	1.13e-05	0.000274	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KIT—testicular cancer	1.13e-05	0.000273	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—STK11—testicular cancer	1.1e-05	0.000266	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—STK11—testicular cancer	1.09e-05	0.000263	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—FGFR3—testicular cancer	1.08e-05	0.000262	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KIT—testicular cancer	1.08e-05	0.000261	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—FGFR3—testicular cancer	1.07e-05	0.000258	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—FGFR3—testicular cancer	1.07e-05	0.000257	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—FGFR3—testicular cancer	1.06e-05	0.000256	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—FGFR3—testicular cancer	1.06e-05	0.000256	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—FGFR3—testicular cancer	1.05e-05	0.000253	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—FGFR3—testicular cancer	1.05e-05	0.000252	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KIT—testicular cancer	9.96e-06	0.000241	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—HPGDS—testicular cancer	9.9e-06	0.000239	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KIT—testicular cancer	9.8e-06	0.000237	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KIT—testicular cancer	9.78e-06	0.000236	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KIT—testicular cancer	9.75e-06	0.000235	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KIT—testicular cancer	9.72e-06	0.000235	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—FGFR3—testicular cancer	9.71e-06	0.000235	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KIT—testicular cancer	9.62e-06	0.000232	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KIT—testicular cancer	9.6e-06	0.000232	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—STK11—testicular cancer	9.32e-06	0.000225	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KIT—testicular cancer	8.92e-06	0.000215	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—STK11—testicular cancer	7.2e-06	0.000174	CbGpPWpGaD
